Concepedia

Jason T. Weiss

JT

Statistics

Publications

8

Citations

994

H-Index

8

Active since

2013

Affiliations

Edinburgh Cancer Research(Current)

University of Edinburgh

Institute of Genetics and Cancer

Loughborough University

Jason T. Weiss is an author at Edinburgh Cancer Research specializing in pharmacy, medicinal chemistry, and palladium-mediated bioorthogonal labeling.

Publications per year

2013–2020

8

Publications

8

Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach

Jason T. Weiss, John C. Dawson, Kenneth G. MacLeod et al. · Nature Communications · 2014 · 349 citations · Full text

, , +14

Development and Bioorthogonal Activation of Palladium-Labile Prodrugs of Gemcitabine

Jason T. Weiss, John C. Dawson, Craig Fraser et al. · Journal of Medicinal Chemistry · 2014 · 203 citations · Full text

, , +14

A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self‐renewal

Alessia Gagliardi, Nicholas P. Mullin, Zi Ying Tan et al. · The EMBO Journal · 2013 · 141 citations · Full text

, , +9

Efficient Palladium-Triggered Release of Vorinostat from a Bioorthogonal Precursor

Belén Rubio‐Ruíz, Jason T. Weiss, Asier Unciti‐Broceta · Journal of Medicinal Chemistry · 2016 · 111 citations · Full text

, , +15

Palladium-Mediated Dealkylation of N-Propargyl-Floxuridine as a Bioorthogonal Oxygen-Independent Prodrug Strategy

Jason T. Weiss, Neil O. Carragher, Asier Unciti‐Broceta · Scientific Reports · 2015 · 71 citations · Full text

, , +11

1–5 of 8